Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Karuna Therapeutics
Pharma
Alkermes reports strong trajectory for Lybalvi, shares up 10%
Alkermes revealed fourth-quarter sales of $56.2 million for Lybalvi, continuing its upward trajectory and triggering a 10% increase in stock price.
Kevin Dunleavy
Feb 15, 2024 1:10pm
‘The Top Line’: The most anticipated drug launches of 2024
Feb 9, 2024 6:00am
JPM24: BMS CEO Boerner focuses on pipeline—even after M&A deals
Jan 8, 2024 2:06pm
Alnylam, Intra-Cellular among RBC's top picks for M&A
Apr 19, 2023 3:20pm